Cargando…

The Outcomes of Using Colistin for Treating Multidrug Resistant Acinetobacter Species Bloodstream Infections

Despite the identification of Acinetobacter baumannii isolates that demonstrate susceptibility to only colistin, this antimicrobial agent was not available in Korea until 2006. The present study examined the outcomes of patients with multidrug resistant (MDR) Acinetobacter species bloodstream infect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Seung-Kwan, Lee, Sang-Oh, Choi, Seong-Ho, Choi, Jae-Phil, Kim, Sung-Han, Jeong, Jin-Yong, Choi, Sang-Ho, Woo, Jun Hee, Kim, Yang Soo
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051077/ https://www.ncbi.nlm.nih.gov/pubmed/21394298 http://dx.doi.org/10.3346/jkms.2011.26.3.325

Ejemplares similares

In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii
por: Park, Gyun Cheol, et al.
Publicado: (2016)

Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients
por: Kim, Won-Young, et al.
Publicado: (2016)

In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii
por: Bae, Seongman, et al.
Publicado: (2016)

In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia
por: Ku, Nam Su, et al.
Publicado: (2019)

Inhaled Colistin for Treatment of Pneumonia due to Colistin-Only-Susceptible Acinetobacter baumannii
por: Choi, Hee Kyoung, et al.
Publicado: (2014)

Transition of colistin dependence into colistin resistance in Acinetobacter baumannii
por: Lee, Ji-Young, et al.
Publicado: (2017)

Intravenous Colistin in the treatment of multidrug-resistant Acinetobacter in neonates
por: Al-lawama, Manar, et al.
Publicado: (2016)

Multidrug-resistant Acinetobacter meningitis treated by intrathecal colistin
por: Singh, Rajesh K., et al.
Publicado: (2017)

Two types of colistin heteroresistance in Acinetobacter baumannii isolates
por: Hong, Yoon-Kyoung, et al.
Publicado: (2020)

Analysis of the Extracellular Proteome of Colistin-Resistant Korean Acinetobacter baumannii Strains
por: Lee, Sang-Yeop, et al.
Publicado: (2020)

Risk and Outcome of Infective Endocarditis in Streptococcal Bloodstream Infections according to Streptococcal Species
por: Seo, Hyeonji, et al.
Publicado: (2023)

Differences in Colistin-resistant Acinetobacter baumannii Clinical Isolates Between Patients With and Without Prior Colistin Treatment
por: Park, Yu Jin, et al.
Publicado: (2018)

204. Antagonistic Effect of Colistin on Vancomycin Activity Against Methicillin-Resistant Staphylococcus aureus in in vitro and in vivo Studies
por: Choi, Sungim, et al.
Publicado: (2019)

61. Short- versus prolonged-courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection
por: Bae, Moonsuk, et al.
Publicado: (2021)

Comparison of colistin monotherapy and non-colistin combinations in the treatment of multi-drug resistant Acinetobacter spp. bloodstream infections: A Multicenter retrospective analysis
por: Balkan, Ilker Inanc, et al.
Publicado: (2015)

Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients With Carbapenem-Resistant Acinetobacter baumannii Bacteremia
por: Son, Hyo-Ju, et al.
Publicado: (2020)

Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii
por: Nordqvist, H., et al.
Publicado: (2016)

In vitro synergistic activity of colistin and teicoplanin combination against multidrug-resistant Acinetobacter spp
por: Rady, Osama Mohamed Samy Mohamed, et al.
Publicado: (2022)

Effects of colistin and tigecycline on multidrug-resistant Acinetobacter baumannii biofilms: advantages and disadvantages of their combination
por: Sato, Yoshinori, et al.
Publicado: (2021)

Colistin, Hot Potato for the Therapy of Carbapenem-resistant Acinetobacter baumannii infections
por: Park, Sang-Won
Publicado: (2019)

Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis
por: Huang, Chienhsiu, et al.
Publicado: (2022)

Colistin Dependency among Colistin-Heteroresistant Acinetobacter baumannii Isolates
por: Kon, Hadas, et al.
Publicado: (2021)

Evaluation of the synergistic effect of a combination of colistin and tigecycline against multidrug-resistant Acinetobacter baumannii
por: Kaya, Ilkem Acar, et al.
Publicado: (2017)

Sulbactam and Colistin Susceptibility Pattern Among Multidrug-Resistant Acinetobacter Isolates From Respiratory Samples
por: Sengupta, Mallika, et al.
Publicado: (2022)

Colistin potentiation in multidrug-resistant Acinetobacter baumannii by a non-cytotoxic guanidine derivative of silver
por: Kumar, Deepak, et al.
Publicado: (2023)

Replacement of the Dominant ST191 Clone by ST369 Among Carbapenem-Resistant Acinetobacter baumannii Bloodstream Isolates at a Tertiary Care Hospital in South Korea
por: Kim, Seong Eun, et al.
Publicado: (2022)

Socioeconomic burden of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Korea
por: Kim, Chung-Jong, et al.
Publicado: (2022)

Multidrug-Resistant Acinetobacter baumannii May Cause Patients to Develop Polymicrobial Bloodstream Infection
por: Chen, Qingqing, et al.
Publicado: (2022)

Colistin Resistance in Escherichia coli Isolates From Patients With Bloodstream Infection in Korea
por: Kim, Young Ah, et al.
Publicado: (2017)

Isolation of multidrug-resistant (MDR) Mycobacterium bovis from a dog in Korea
por: CHO, Ho-Seong, et al.
Publicado: (2022)

Colistin Therapy in a 23-Week Gestational-Age Neonate with Multidrug-Resistant Acinetobacter baumannii Pneumonia
por: Lulic-Botica, Mirjana, et al.
Publicado: (2011)

A Review of Novel Combinations of Colistin and Lipopeptide or Glycopeptide Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii
por: Claeys, Kimberly C., et al.
Publicado: (2014)

Place of Colistin-Rifampicin Association in the Treatment of Multidrug-Resistant Acinetobacter Baumannii Meningitis: A Case Study
por: Souhail, Dahraoui, et al.
Publicado: (2016)

Colistin and tigecycline for management of external ventricular device-related ventriculitis due to multidrug-resistant Acinetobacter baumannii
por: Shrestha, Gentle Sunder, et al.
Publicado: (2016)

Synergistic Antimicrobial Effect of Colistin in Combination with Econazole against Multidrug-Resistant Acinetobacter baumannii and Its Persisters
por: Xie, Miaomiao, et al.
Publicado: (2022)

2171. Minocycline Susceptibility in Carbapenem-Resistant Acinetobacter baumannii Blood Isolates in South Korea: Role of tetB Gene in Resistance
por: Kim, Taeeun, et al.
Publicado: (2023)

Multiple heteroresistance to tigecycline and colistin in Acinetobacter baumannii isolates and its implications for combined antibiotic treatment
por: Jo, Jeongwoo, et al.
Publicado: (2023)

Antibiotic treatment modulates protein components of cytotoxic outer membrane vesicles of multidrug-resistant clinical strain, Acinetobacter baumannii DU202
por: Yun, Sung Ho, et al.
Publicado: (2018)

In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant Acinetobacter baumannii Using the Broth Microdilution Checkerboard and Time-Kill Methods
por: Rodjun, Vipavee, et al.
Publicado: (2020)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Park, Jae-Min, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n1m53468lvastcu0395fuu8urp